Top compounds associated with response to SRI


Feature Type Standardized
Nominal ANOVA
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.018 0.6
mRNA manumycin A CTRPv2 pan-cancer AAC -0.016 0.6
mRNA prima-1 CTRPv2 pan-cancer AAC -0.016 0.6
mRNA GDC-0941 gCSI pan-cancer AAC -0.03 0.6
mRNA Bax channel blocker CTRPv2 pan-cancer AAC -0.019 0.6
mRNA ABT-888 CTRPv2 pan-cancer AAC 0.018 0.6
mRNA canertinib CTRPv2 pan-cancer AAC 0.018 0.6
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.017 0.6
mRNA AT13387 CTRPv2 pan-cancer AAC -0.023 0.6
mRNA BMS-536924 GDSC1000 pan-cancer AAC -0.016 0.6
Download CSV